In parallel work, 68Ga-labelled urea-based PSMA inhibitors have shown great promise for PSMA-specific tumour imaging with PET 11,12 and analogues labelled with 177Lu are being evaluated for therapy 13. Here, FOLH1 is linked to neoplasm.